<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-05-01" modified="2020-04-22" version="223">
<accession>P26358</accession>
<accession>A0AV63</accession>
<accession>B7ZLW6</accession>
<accession>Q9UHG5</accession>
<accession>Q9ULA2</accession>
<accession>Q9UMZ6</accession>
<name>DNMT1_HUMAN</name>
<protein>
<recommendedName>
<fullName>DNA (cytosine-5)-methyltransferase 1</fullName>
<shortName>Dnmt1</shortName>
<ecNumber>2.1.1.37</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CXXC-type zinc finger protein 9</fullName>
</alternativeName>
<alternativeName>
<fullName>DNA methyltransferase HsaI</fullName>
<shortName>DNA MTase HsaI</shortName>
<shortName>M.HsaI</shortName>
</alternativeName>
<alternativeName>
<fullName>MCMT</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">DNMT1</name>
<name type="synonym">AIM</name>
<name type="synonym">CXXC9</name>
<name type="synonym">DNMT</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Nucleic Acids Res." volume="20" first="2287" last="2291">
<title>Isolation and characterization of the cDNA encoding human DNA methyltransferase.</title>
<authorList>
<person name="Yen R.-W.C."/>
<person name="Vertino P.M."/>
<person name="Nelkin B.D."/>
<person name="Yu J.J."/>
<person name="Deiry W.E."/>
<person name="Cumaraswamy A."/>
<person name="Lennon G.G."/>
<person name="Trask B.J."/>
<person name="Celano P."/>
<person name="Baylin S.B."/>
</authorList>
<dbReference type="PubMed" id="1594447"/>
<dbReference type="DOI" id="10.1093/nar/20.9.2287"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="31092" last="31097">
<title>New 5' regions of the murine and human genes for DNA (cytosine-5)-methyltransferase.</title>
<authorList>
<person name="Yoder J.A."/>
<person name="Yen R.-W.C."/>
<person name="Vertino P.M."/>
<person name="Bestor T.H."/>
<person name="Baylin S.B."/>
</authorList>
<dbReference type="PubMed" id="8940105"/>
<dbReference type="DOI" id="10.1074/jbc.271.49.31092"/>
</citation>
<scope>SEQUENCE REVISION TO N-TERMINUS</scope>
</reference>
<reference key="3">
<citation type="submission" date="1999-08" db="EMBL/GenBank/DDBJ databases">
<title>Human DNA methyltransferase (DNMT1) is alternatively spliced.</title>
<authorList>
<person name="Li L.C."/>
<person name="Au H."/>
<person name="Chui R."/>
<person name="Dahiya R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="9751" last="9756">
<title>Two major forms of DNA (cytosine-5) methyltransferase in human somatic tissues.</title>
<authorList>
<person name="Hsu D.-W."/>
<person name="Lin M.-J."/>
<person name="Lee T.-L."/>
<person name="Wen S.-C."/>
<person name="Chen X."/>
<person name="Shen C.-K.J."/>
</authorList>
<dbReference type="PubMed" id="10449766"/>
<dbReference type="DOI" id="10.1073/pnas.96.17.9751"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="10754" last="10760">
<title>Characterization of the human DNA methyltransferase splice variant Dnmt1b.</title>
<authorList>
<person name="Bonfils C."/>
<person name="Beaulieu N."/>
<person name="Chan E."/>
<person name="Cotton-Montpetit J."/>
<person name="MacLeod A.R."/>
</authorList>
<dbReference type="PubMed" id="10753866"/>
<dbReference type="DOI" id="10.1074/jbc.275.15.10754"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1997" name="Science" volume="277" first="1996" last="2000">
<title>Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.</title>
<authorList>
<person name="Chuang L.S.-H."/>
<person name="Ian H.-I."/>
<person name="Koh T.-W."/>
<person name="Ng H.-H."/>
<person name="Xu G."/>
<person name="Li B.F.L."/>
</authorList>
<dbReference type="PubMed" id="9302295"/>
<dbReference type="DOI" id="10.1126/science.277.5334.1996"/>
</citation>
<scope>INTERACTION WITH PCNA</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Genes Cells" volume="5" first="677" last="688">
<title>MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase.</title>
<authorList>
<person name="Tatematsu K."/>
<person name="Yamazaki T."/>
<person name="Ishikawa F."/>
</authorList>
<dbReference type="PubMed" id="10947852"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.2000.00359.x"/>
</citation>
<scope>INTERACTION WITH MBD2 AND MBD3</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="269" last="277">
<title>DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.</title>
<authorList>
<person name="Rountree M.R."/>
<person name="Bachman K.E."/>
<person name="Baylin S.B."/>
</authorList>
<dbReference type="PubMed" id="10888872"/>
<dbReference type="DOI" id="10.1038/77023"/>
</citation>
<scope>INTERACTION WITH HDAC2 AND DMAP1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="338" last="342">
<title>DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.</title>
<authorList>
<person name="Robertson K.D."/>
<person name="Ait-Si-Ali S."/>
<person name="Yokochi T."/>
<person name="Wade P.A."/>
<person name="Jones P.L."/>
<person name="Wolffe A.P."/>
</authorList>
<dbReference type="PubMed" id="10888886"/>
<dbReference type="DOI" id="10.1038/77124"/>
</citation>
<scope>INTERACTION WITH RB1; E2F1 AND HDAC1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Nucleic Acids Res." volume="27" first="2291" last="2298">
<title>The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.</title>
<authorList>
<person name="Robertson K.D."/>
<person name="Uzvolgyi E."/>
<person name="Liang G."/>
<person name="Talmadge C."/>
<person name="Sumegi J."/>
<person name="Gonzales F.A."/>
<person name="Jones P.A."/>
</authorList>
<dbReference type="PubMed" id="10325416"/>
<dbReference type="DOI" id="10.1093/nar/27.11.2291"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="4183" last="4195">
<title>Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases.</title>
<authorList>
<person name="Kim G.-D."/>
<person name="Ni J."/>
<person name="Kelesoglu N."/>
<person name="Roberts R.J."/>
<person name="Pradhan S."/>
</authorList>
<dbReference type="PubMed" id="12145218"/>
<dbReference type="DOI" id="10.1093/emboj/cdf401"/>
</citation>
<scope>INTERACTION WITH DNMT3A AND DNMT3B</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127 AND SER-714</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Nature" volume="439" first="871" last="874">
<title>The Polycomb group protein EZH2 directly controls DNA methylation.</title>
<authorList>
<person name="Vire E."/>
<person name="Brenner C."/>
<person name="Deplus R."/>
<person name="Blanchon L."/>
<person name="Fraga M."/>
<person name="Didelot C."/>
<person name="Morey L."/>
<person name="Van Eynde A."/>
<person name="Bernard D."/>
<person name="Vanderwinden J.-M."/>
<person name="Bollen M."/>
<person name="Esteller M."/>
<person name="Di Croce L."/>
<person name="de Launoit Y."/>
<person name="Fuks F."/>
</authorList>
<dbReference type="PubMed" id="16357870"/>
<dbReference type="DOI" id="10.1038/nature04431"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EED AND EZH2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Nature" volume="446" first="824" last="824">
<authorList>
<person name="Vire E."/>
<person name="Brenner C."/>
<person name="Deplus R."/>
<person name="Blanchon L."/>
<person name="Fraga M."/>
<person name="Didelot C."/>
<person name="Morey L."/>
<person name="Van Eynde A."/>
<person name="Bernard D."/>
<person name="Vanderwinden J.-M."/>
<person name="Bollen M."/>
<person name="Esteller M."/>
<person name="Di Croce L."/>
<person name="de Launoit Y."/>
<person name="Fuks F."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:16357870</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="232" last="236">
<title>Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.</title>
<authorList>
<person name="Schlesinger Y."/>
<person name="Straussman R."/>
<person name="Keshet I."/>
<person name="Farkash S."/>
<person name="Hecht M."/>
<person name="Zimmerman J."/>
<person name="Eden E."/>
<person name="Yakhini Z."/>
<person name="Ben-Shushan E."/>
<person name="Reubinoff B.E."/>
<person name="Bergman Y."/>
<person name="Simon I."/>
<person name="Cedar H."/>
</authorList>
<dbReference type="PubMed" id="17200670"/>
<dbReference type="DOI" id="10.1038/ng1950"/>
</citation>
<scope>DE NOVO DNA METHYLATION OF TARGET GENES</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="10000" last="10009">
<title>CXXC domain of human DNMT1 is essential for enzymatic activity.</title>
<authorList>
<person name="Pradhan M."/>
<person name="Esteve P.-O."/>
<person name="Chin H.G."/>
<person name="Samaranayke M."/>
<person name="Kim G.-D."/>
<person name="Pradhan S."/>
</authorList>
<dbReference type="PubMed" id="18754681"/>
<dbReference type="DOI" id="10.1021/bi8011725"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-653; CYS-656; CYS-659; CYS-664; CYS-667 AND CYS-670</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="2726" last="2735">
<title>DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.</title>
<authorList>
<person name="Sun L."/>
<person name="Huang L."/>
<person name="Nguyen P."/>
<person name="Bisht K.S."/>
<person name="Bar-Sela G."/>
<person name="Ho A.S."/>
<person name="Bradbury C.M."/>
<person name="Yu W."/>
<person name="Cui H."/>
<person name="Lee S."/>
<person name="Trepel J.B."/>
<person name="Feinberg A.P."/>
<person name="Gius D."/>
</authorList>
<dbReference type="PubMed" id="18413740"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-6654"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-732</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Nat. Chem. Biol." volume="4" first="344" last="346">
<title>Protein lysine methyltransferase G9a acts on non-histone targets.</title>
<authorList>
<person name="Rathert P."/>
<person name="Dhayalan A."/>
<person name="Murakami M."/>
<person name="Zhang X."/>
<person name="Tamas R."/>
<person name="Jurkowska R."/>
<person name="Komatsu Y."/>
<person name="Shinkai Y."/>
<person name="Cheng X."/>
<person name="Jeltsch A."/>
</authorList>
<dbReference type="PubMed" id="18438403"/>
<dbReference type="DOI" id="10.1038/nchembio.88"/>
</citation>
<scope>METHYLATION AT LYS-70</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127; SER-143; SER-152; SER-154 AND SER-394</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Biochem. J." volume="421" first="449" last="461">
<title>SUMOylation enhances DNA methyltransferase 1 activity.</title>
<authorList>
<person name="Lee B."/>
<person name="Muller M.T."/>
</authorList>
<dbReference type="PubMed" id="19450230"/>
<dbReference type="DOI" id="10.1042/bj20090142"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>INTERACTION WITH UBC9</scope>
<scope>MUTAGENESIS OF CYS-1226</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Cell. Biochem." volume="106" first="521" last="528">
<title>Dimerization of DNA methyltransferase 1 is mediated by its regulatory domain.</title>
<authorList>
<person name="Fellinger K."/>
<person name="Rothbauer U."/>
<person name="Felle M."/>
<person name="Laengst G."/>
<person name="Leonhardt H."/>
</authorList>
<dbReference type="PubMed" id="19173286"/>
<dbReference type="DOI" id="10.1002/jcb.22071"/>
</citation>
<scope>HOMODIMERIZATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-173; LYS-1111; LYS-1113 AND LYS-1115</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394 AND SER-714</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="409" first="187" last="192">
<title>Phosphorylation of human DNMT1: implication of cyclin-dependent kinases.</title>
<authorList>
<person name="Lavoie G."/>
<person name="St-Pierre Y."/>
</authorList>
<dbReference type="PubMed" id="21565170"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2011.04.115"/>
</citation>
<scope>PHOSPHORYLATION AT SER-154</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="4720" last="4734">
<title>SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.</title>
<authorList>
<person name="Peng L."/>
<person name="Yuan Z."/>
<person name="Ling H."/>
<person name="Fukasawa K."/>
<person name="Robertson K."/>
<person name="Olashaw N."/>
<person name="Koomen J."/>
<person name="Chen J."/>
<person name="Lane W.S."/>
<person name="Seto E."/>
</authorList>
<dbReference type="PubMed" id="21947282"/>
<dbReference type="DOI" id="10.1128/mcb.06147-11"/>
</citation>
<scope>ACETYLATION AT LYS-160; LYS-188; LYS-259; LYS-366; LYS-749; LYS-891; LYS-957; LYS-961; LYS-975; LYS-1054; LYS-1111; LYS-1113; LYS-1115; LYS-1117; LYS-1349 AND LYS-1415</scope>
<scope>DEACETYLATION BY SIRT1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Nat. Struct. Mol. Biol." volume="18" first="42" last="48">
<title>A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability.</title>
<authorList>
<person name="Esteve P.O."/>
<person name="Chang Y."/>
<person name="Samaranayake M."/>
<person name="Upadhyay A.K."/>
<person name="Horton J.R."/>
<person name="Feehery G.R."/>
<person name="Cheng X."/>
<person name="Pradhan S."/>
</authorList>
<dbReference type="PubMed" id="21151116"/>
<dbReference type="DOI" id="10.1038/nsmb.1939"/>
</citation>
<scope>METHYLATION AT LYS-142</scope>
<scope>PHOSPHORYLATION AT SER-143</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Nucleic Acids Res." volume="39" first="8355" last="8365">
<title>The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1.</title>
<authorList>
<person name="Felle M."/>
<person name="Joppien S."/>
<person name="Nemeth A."/>
<person name="Diermeier S."/>
<person name="Thalhammer V."/>
<person name="Dobner T."/>
<person name="Kremmer E."/>
<person name="Kappler R."/>
<person name="Langst G."/>
</authorList>
<dbReference type="PubMed" id="21745816"/>
<dbReference type="DOI" id="10.1093/nar/gkr528"/>
</citation>
<scope>INTERACTION WITH USP7 AND UHRF1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127; SER-133 AND SER-714</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127; THR-137; SER-143; SER-154; THR-166; SER-312; SER-394; SER-398; SER-549; SER-714 AND SER-878</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Elife" volume="3" first="E02313" last="E02313">
<title>A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype.</title>
<authorList>
<person name="Serra R.W."/>
<person name="Fang M."/>
<person name="Park S.M."/>
<person name="Hutchinson L."/>
<person name="Green M.R."/>
</authorList>
<dbReference type="PubMed" id="24623306"/>
<dbReference type="DOI" id="10.7554/elife.02313"/>
</citation>
<scope>FUNCTION</scope>
<scope>POSSIBLE IDENTIFICATION IN A COREPRESSOR COMPLEX</scope>
<scope>CHROMATIN-BINDING</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1609</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-259 AND LYS-1609</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="15344" last="15351">
<title>The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of Dnmt1.</title>
<authorList>
<person name="Syeda F."/>
<person name="Fagan R.L."/>
<person name="Wean M."/>
<person name="Avvakumov G.V."/>
<person name="Walker J.R."/>
<person name="Xue S."/>
<person name="Dhe-Paganon S."/>
<person name="Brenner C."/>
</authorList>
<dbReference type="PubMed" id="21389349"/>
<dbReference type="DOI" id="10.1074/jbc.m110.209882"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 351-600 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Science" volume="331" first="1036" last="1040">
<title>Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation.</title>
<authorList>
<person name="Song J."/>
<person name="Rechkoblit O."/>
<person name="Bestor T.H."/>
<person name="Patel D.J."/>
</authorList>
<dbReference type="PubMed" id="21163962"/>
<dbReference type="DOI" id="10.1126/science.1195380"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 646-1600 IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE AND DNA</scope>
<scope>AUTOINHIBITORY LINKER</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="595" last="600">
<title>Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.</title>
<authorList>
<person name="Klein C.J."/>
<person name="Botuyan M.V."/>
<person name="Wu Y."/>
<person name="Ward C.J."/>
<person name="Nicholson G.A."/>
<person name="Hammans S."/>
<person name="Hojo K."/>
<person name="Yamanishi H."/>
<person name="Karpf A.R."/>
<person name="Wallace D.C."/>
<person name="Simon M."/>
<person name="Lander C."/>
<person name="Boardman L.A."/>
<person name="Cunningham J.M."/>
<person name="Smith G.E."/>
<person name="Litchy W.J."/>
<person name="Boes B."/>
<person name="Atkinson E.J."/>
<person name="Middha S."/>
<person name="Dyck P.J.B."/>
<person name="Parisi J.E."/>
<person name="Mer G."/>
<person name="Smith D.I."/>
<person name="Dyck P.J."/>
</authorList>
<dbReference type="PubMed" id="21532572"/>
<dbReference type="DOI" id="10.1038/ng.830"/>
</citation>
<scope>VARIANTS HSN1E 490-GLU-TYR-491 AND CYS-495</scope>
<scope>CHARACTERIZATION OF VARIANTS HSN1E 490-GLU-TYR-491 AND CYS-495</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Hum. Mol. Genet." volume="21" first="2205" last="2210">
<title>Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.</title>
<authorList>
<person name="Winkelmann J."/>
<person name="Lin L."/>
<person name="Schormair B."/>
<person name="Kornum B.R."/>
<person name="Faraco J."/>
<person name="Plazzi G."/>
<person name="Melberg A."/>
<person name="Cornelio F."/>
<person name="Urban A.E."/>
<person name="Pizza F."/>
<person name="Poli F."/>
<person name="Grubert F."/>
<person name="Wieland T."/>
<person name="Graf E."/>
<person name="Hallmayer J."/>
<person name="Strom T.M."/>
<person name="Mignot E."/>
</authorList>
<dbReference type="PubMed" id="22328086"/>
<dbReference type="DOI" id="10.1093/hmg/dds035"/>
</citation>
<scope>VARIANTS ADCADN VAL-554; ALA-589 AND PHE-590</scope>
</reference>
<comment type="function">
<text evidence="31 32 34 44">Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance. Associates with chromatin during G2 and M phases to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development. DNA methylation is coordinated with methylation of histones. Mediates transcriptional repression by direct binding to HDAC2. In association with DNMT3B and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). Promotes tumor growth (PubMed:24623306).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="25">
<text>a 2'-deoxycytidine in DNA + S-adenosyl-L-methionine = a 5-methyl-2'-deoxycytidine in DNA + H(+) + S-adenosyl-L-homocysteine</text>
<dbReference type="Rhea" id="RHEA:13681"/>
<dbReference type="Rhea" id="RHEA-COMP:11369"/>
<dbReference type="Rhea" id="RHEA-COMP:11370"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57856"/>
<dbReference type="ChEBI" id="CHEBI:59789"/>
<dbReference type="ChEBI" id="CHEBI:85452"/>
<dbReference type="ChEBI" id="CHEBI:85454"/>
<dbReference type="EC" id="2.1.1.37"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="19 27 28 29 30 31 35 36 41 44 45">Homodimer (PubMed:19173286). Forms a stable complex with E2F1, BB1 and HDAC1 (PubMed:10888886). Forms a complex with DMAP1 and HDAC2, with direct interaction (PubMed:10888872). Interacts with the PRC2/EED-EZH2 complex (PubMed:16357870). Probably part of a corepressor complex containing ZNF304, TRIM28, SETDB1 and DNMT1 (PubMed:24623306). Interacts with UHRF1; promoting its recruitment to hemimethylated DNA (PubMed:21745816). Interacts with USP7, promoting its deubiquitination (PubMed:21745816). Interacts with PCNA (PubMed:9302295). Interacts with MBD2 and MBD3 (PubMed:10947852). Interacts with DNMT3A and DNMT3B (PubMed:12145218). Interacts with UBC9 (PubMed:19450230). Interacts with CSNK1D (By similarity). Interacts with HDAC1 (By similarity). Interacts with BAZ2A/TIP5 (By similarity). Interacts with SIRT7 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-923794">
<id>O75530</id>
<label>EED</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-530054">
<id>Q15910</id>
<label>EZH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-2608731">
<id>Q77UV9</id>
<label>KIE-2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-15602554">
<id>Q9QR71</id>
<label>LANA1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-746484">
<id>P48552</id>
<label>NRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-355676">
<id>P09874</id>
<label>PARP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-1268586">
<id>Q8WTS6</id>
<label>SETD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719459">
<id>P26358</id>
</interactant>
<interactant intactId="EBI-1548946">
<id>Q96T88</id>
<label>UHRF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="30">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P26358-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P26358-2</id>
<name>2</name>
<name>Dnmt1b</name>
<sequence type="described" ref="VSP_005618"/>
</isoform>
<isoform>
<id>P26358-3</id>
<name>3</name>
<sequence type="described" ref="VSP_005617"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="26">Ubiquitous; highly expressed in fetal tissues, heart, kidney, placenta, peripheral blood mononuclear cells, and expressed at lower levels in spleen, lung, brain, small intestine, colon, liver, and skeletal muscle. Isoform 2 is less expressed than isoform 1.</text>
</comment>
<comment type="induction">
<text>Its abundance is reduced to non detectable levels at the G0 phase of the cell cycle and is dramatically induced upon entrance into the S-phase of the cell cycle.</text>
</comment>
<comment type="domain">
<text>The N-terminal part is required for homodimerization and acts as a regulatory domain.</text>
</comment>
<comment type="domain">
<text evidence="38">The CXXC-type zinc finger specifically binds to unmethylated CpG dinucleotides, positioning the autoinhibitory linker between the DNA and the active site, thus providing a mechanism to ensure that only hemimethylated CpG dinucleotides undergo methylation.</text>
</comment>
<comment type="PTM">
<text evidence="36">Sumoylated; sumoylation increases activity.</text>
</comment>
<comment type="PTM">
<text evidence="42">Acetylation on multiple lysines, mainly by KAT2B/PCAF, regulates cell cycle G(2)/M transition. Deacetylation of Lys-1349 and Lys-1415 by SIRT1 increases methyltransferase activity.</text>
</comment>
<comment type="PTM">
<text evidence="37 40">Phosphorylation of Ser-154 by CDKs is important for enzymatic activity and protein stability. Phosphorylation of Ser-143 by AKT1 prevents methylation by SETD7 therebye increasing DNMT1 stability.</text>
</comment>
<comment type="PTM">
<text evidence="33 37">Methylation at Lys-142 by SETD7 promotes DNMT1 proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="18">Ubiquitinated by UHRF1; interaction with USP7 counteracts ubiquitination by UHRF1 by promoting deubiquitination and preventing degradation by the proteasome.</text>
</comment>
<comment type="disease" evidence="39">
<disease id="DI-03189">
<name>Neuropathy, hereditary sensory, 1E</name>
<acronym>HSN1E</acronym>
<description>A neurodegenerative disorder characterized by adult onset of progressive peripheral sensory loss associated with progressive hearing impairment and early-onset dementia.</description>
<dbReference type="MIM" id="614116"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="43">
<disease id="DI-03793">
<name>Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant</name>
<acronym>ADCADN</acronym>
<description>An autosomal dominant neurologic disorder characterized by adult onset of progressive cerebellar ataxia, narcolepsy, cataplexy, sensorineural deafness, and dementia. More variable features include optic atrophy, sensory neuropathy, psychosis, and depression.</description>
<dbReference type="MIM" id="604121"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the class I-like SAM-binding methyltransferase superfamily. C5-methyltransferase family.</text>
</comment>
<comment type="sequence caution" evidence="48">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAD54507" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/DNMT1ID40347ch19p13.html"/>
</comment>
<dbReference type="EC" id="2.1.1.37"/>
<dbReference type="EMBL" id="X63692">
<property type="protein sequence ID" value="CAA45219.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF180682">
<property type="protein sequence ID" value="AAF23609.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010077">
<property type="protein sequence ID" value="AAD54507.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011511">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC020931">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126227">
<property type="protein sequence ID" value="AAI26228.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC144093">
<property type="protein sequence ID" value="AAI44094.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AH008119">
<property type="protein sequence ID" value="AAD51619.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12228.1">
<molecule id="P26358-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45958.1">
<molecule id="P26358-2"/>
</dbReference>
<dbReference type="PIR" id="S22610">
<property type="entry name" value="S22610"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124295.1">
<molecule id="P26358-2"/>
<property type="nucleotide sequence ID" value="NM_001130823.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305659.1">
<property type="nucleotide sequence ID" value="NM_001318730.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305660.1">
<property type="nucleotide sequence ID" value="NM_001318731.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001370.1">
<molecule id="P26358-1"/>
<property type="nucleotide sequence ID" value="NM_001379.3"/>
</dbReference>
<dbReference type="PDB" id="3EPZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=351-600"/>
</dbReference>
<dbReference type="PDB" id="3PTA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A=646-1600"/>
</dbReference>
<dbReference type="PDB" id="3SWR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="A=601-1600"/>
</dbReference>
<dbReference type="PDB" id="4WXX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A/B=351-1600"/>
</dbReference>
<dbReference type="PDB" id="4YOC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.92"/>
<property type="chains" value="A=600-1600"/>
</dbReference>
<dbReference type="PDB" id="4Z96">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="C=1098-1129"/>
</dbReference>
<dbReference type="PDB" id="4Z97">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C=1098-1129"/>
</dbReference>
<dbReference type="PDB" id="5WVO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=351-600"/>
</dbReference>
<dbReference type="PDB" id="5YDR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=351-599"/>
</dbReference>
<dbReference type="PDB" id="6K3A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B/D/F=161-180"/>
</dbReference>
<dbReference type="PDBsum" id="3EPZ"/>
<dbReference type="PDBsum" id="3PTA"/>
<dbReference type="PDBsum" id="3SWR"/>
<dbReference type="PDBsum" id="4WXX"/>
<dbReference type="PDBsum" id="4YOC"/>
<dbReference type="PDBsum" id="4Z96"/>
<dbReference type="PDBsum" id="4Z97"/>
<dbReference type="PDBsum" id="5WVO"/>
<dbReference type="PDBsum" id="5YDR"/>
<dbReference type="PDBsum" id="6K3A"/>
<dbReference type="SMR" id="P26358"/>
<dbReference type="BioGrid" id="108123">
<property type="interactions" value="127"/>
</dbReference>
<dbReference type="CORUM" id="P26358"/>
<dbReference type="DIP" id="DIP-39693N"/>
<dbReference type="ELM" id="P26358"/>
<dbReference type="IntAct" id="P26358">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="MINT" id="P26358"/>
<dbReference type="STRING" id="9606.ENSP00000352516"/>
<dbReference type="BindingDB" id="P26358"/>
<dbReference type="ChEMBL" id="CHEMBL1993"/>
<dbReference type="DrugBank" id="DB00928">
<property type="generic name" value="Azacitidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01262">
<property type="generic name" value="Decitabine"/>
</dbReference>
<dbReference type="DrugBank" id="DB12116">
<property type="generic name" value="Epigallocatechin gallate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01099">
<property type="generic name" value="Flucytosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05668">
<property type="generic name" value="Palifosfamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01035">
<property type="generic name" value="Procainamide"/>
</dbReference>
<dbReference type="DrugCentral" id="P26358"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2605"/>
<dbReference type="REBASE" id="1161">
<property type="entry name" value="M.HsaDnmt1A"/>
</dbReference>
<dbReference type="REBASE" id="4240">
<property type="entry name" value="M.HsaDnmt1B"/>
</dbReference>
<dbReference type="iPTMnet" id="P26358"/>
<dbReference type="PhosphoSitePlus" id="P26358"/>
<dbReference type="SwissPalm" id="P26358"/>
<dbReference type="BioMuta" id="DNMT1"/>
<dbReference type="DMDM" id="12231019"/>
<dbReference type="EPD" id="P26358"/>
<dbReference type="jPOST" id="P26358"/>
<dbReference type="MassIVE" id="P26358"/>
<dbReference type="MaxQB" id="P26358"/>
<dbReference type="PaxDb" id="P26358"/>
<dbReference type="PeptideAtlas" id="P26358"/>
<dbReference type="PRIDE" id="P26358"/>
<dbReference type="ProteomicsDB" id="54320">
<molecule id="P26358-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54321">
<molecule id="P26358-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54322">
<molecule id="P26358-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="1052">
<property type="antibodies" value="1521 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000340748">
<molecule id="P26358-1"/>
<property type="protein sequence ID" value="ENSP00000345739"/>
<property type="gene ID" value="ENSG00000130816"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359526">
<molecule id="P26358-2"/>
<property type="protein sequence ID" value="ENSP00000352516"/>
<property type="gene ID" value="ENSG00000130816"/>
</dbReference>
<dbReference type="GeneID" id="1786"/>
<dbReference type="KEGG" id="hsa:1786"/>
<dbReference type="UCSC" id="uc002mng.4">
<molecule id="P26358-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1786"/>
<dbReference type="DisGeNET" id="1786"/>
<dbReference type="GeneCards" id="DNMT1"/>
<dbReference type="GeneReviews" id="DNMT1"/>
<dbReference type="HGNC" id="HGNC:2976">
<property type="gene designation" value="DNMT1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000130816">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="DNMT1"/>
<dbReference type="MIM" id="126375">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="604121">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614116">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P26358"/>
<dbReference type="OpenTargets" id="ENSG00000130816"/>
<dbReference type="Orphanet" id="314404">
<property type="disease" value="Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="456318">
<property type="disease" value="Hereditary sensory neuropathy-deafness-dementia syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27443"/>
<dbReference type="eggNOG" id="ENOG410IF68">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0270">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000005100"/>
<dbReference type="HOGENOM" id="CLU_003040_0_0_1"/>
<dbReference type="InParanoid" id="P26358"/>
<dbReference type="KO" id="K00558"/>
<dbReference type="OMA" id="HLCAFDT"/>
<dbReference type="PhylomeDB" id="P26358"/>
<dbReference type="TreeFam" id="TF328926"/>
<dbReference type="BRENDA" id="2.1.1.37">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-212300">
<property type="pathway name" value="PRC2 methylates histones and DNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-427413">
<property type="pathway name" value="NoRC negatively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4655427">
<property type="pathway name" value="SUMOylation of DNA methylation proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5334118">
<property type="pathway name" value="DNA methylation"/>
</dbReference>
<dbReference type="SIGNOR" id="P26358"/>
<dbReference type="ChiTaRS" id="DNMT1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P26358"/>
<dbReference type="GeneWiki" id="DNMT1"/>
<dbReference type="GenomeRNAi" id="1786"/>
<dbReference type="Pharos" id="P26358">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P26358"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P26358">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130816">
<property type="expression patterns" value="Expressed in oocyte and 214 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P26358">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P26358">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005721">
<property type="term" value="C:pericentric heterochromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005657">
<property type="term" value="C:replication fork"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003886">
<property type="term" value="F:DNA (cytosine-5-)-methyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009008">
<property type="term" value="F:DNA-methyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008327">
<property type="term" value="F:methyl-CpG binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071230">
<property type="term" value="P:cellular response to amino acid stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006325">
<property type="term" value="P:chromatin organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006306">
<property type="term" value="P:DNA methylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043045">
<property type="term" value="P:DNA methylation involved in embryo development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010424">
<property type="term" value="P:DNA methylation on cytosine within a CG sequence"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016458">
<property type="term" value="P:gene silencing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010216">
<property type="term" value="P:maintenance of DNA methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045814">
<property type="term" value="P:negative regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051573">
<property type="term" value="P:negative regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1905460">
<property type="term" value="P:negative regulation of vascular associated smooth muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905931">
<property type="term" value="P:negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051571">
<property type="term" value="P:positive regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090309">
<property type="term" value="P:positive regulation of methylation-dependent chromatin silencing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904707">
<property type="term" value="P:positive regulation of vascular smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR001025">
<property type="entry name" value="BAH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018117">
<property type="entry name" value="C5_DNA_meth_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001525">
<property type="entry name" value="C5_MeTfrase"/>
</dbReference>
<dbReference type="InterPro" id="IPR031303">
<property type="entry name" value="C5_meth_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR022702">
<property type="entry name" value="Cytosine_MeTrfase1_RFD"/>
</dbReference>
<dbReference type="InterPro" id="IPR010506">
<property type="entry name" value="DMAP1-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR017198">
<property type="entry name" value="DNMT1-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR029063">
<property type="entry name" value="SAM-dependent_MTases"/>
</dbReference>
<dbReference type="InterPro" id="IPR002857">
<property type="entry name" value="Znf_CXXC"/>
</dbReference>
<dbReference type="Pfam" id="PF01426">
<property type="entry name" value="BAH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF06464">
<property type="entry name" value="DMAP_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00145">
<property type="entry name" value="DNA_methylase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12047">
<property type="entry name" value="DNMT1-RFD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02008">
<property type="entry name" value="zf-CXXC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037404">
<property type="entry name" value="DNMT1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00105">
<property type="entry name" value="C5METTRFRASE"/>
</dbReference>
<dbReference type="SMART" id="SM00439">
<property type="entry name" value="BAH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM01137">
<property type="entry name" value="DMAP_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53335">
<property type="entry name" value="SSF53335"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51038">
<property type="entry name" value="BAH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00094">
<property type="entry name" value="C5_MTASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00095">
<property type="entry name" value="C5_MTASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51912">
<property type="entry name" value="DMAP1_BIND"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51679">
<property type="entry name" value="SAM_MT_C5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51058">
<property type="entry name" value="ZF_CXXC"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0209">Deafness</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0489">Methyltransferase</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0949">S-adenosyl-L-methionine</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="DNA (cytosine-5)-methyltransferase 1" id="PRO_0000088034">
<location>
<begin position="1"/>
<end position="1616"/>
</location>
</feature>
<feature type="domain" description="DMAP1-binding" evidence="24">
<location>
<begin position="16"/>
<end position="109"/>
</location>
</feature>
<feature type="domain" description="BAH 1" evidence="21">
<location>
<begin position="755"/>
<end position="880"/>
</location>
</feature>
<feature type="domain" description="BAH 2" evidence="21">
<location>
<begin position="972"/>
<end position="1100"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="1109"/>
<end position="1110"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="1111"/>
<end position="1112"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="1113"/>
<end position="1114"/>
</location>
</feature>
<feature type="repeat" description="4">
<location>
<begin position="1115"/>
<end position="1116"/>
</location>
</feature>
<feature type="repeat" description="5">
<location>
<begin position="1117"/>
<end position="1118"/>
</location>
</feature>
<feature type="repeat" description="6; approximate">
<location>
<begin position="1119"/>
<end position="1120"/>
</location>
</feature>
<feature type="domain" description="SAM-dependent MTase C5-type" evidence="23">
<location>
<begin position="1139"/>
<end position="1599"/>
</location>
</feature>
<feature type="zinc finger region" description="CXXC-type" evidence="22">
<location>
<begin position="646"/>
<end position="692"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the PRC2/EED-EZH2 complex" evidence="18">
<location>
<begin position="1"/>
<end position="336"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNMT3A" evidence="30">
<location>
<begin position="1"/>
<end position="148"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DMAP1" evidence="27">
<location>
<begin position="1"/>
<end position="120"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNMT3B" evidence="30">
<location>
<begin position="149"/>
<end position="217"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PCNA" evidence="45">
<location>
<begin position="163"/>
<end position="174"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the PRC2/EED-EZH2 complex" evidence="18">
<location>
<begin position="308"/>
<end position="606"/>
</location>
</feature>
<feature type="region of interest" description="Homodimerization">
<location>
<begin position="310"/>
<end position="502"/>
</location>
</feature>
<feature type="region of interest" description="DNA replication foci-targeting sequence" evidence="18">
<location>
<begin position="331"/>
<end position="550"/>
</location>
</feature>
<feature type="region of interest" description="Required for activity">
<location>
<begin position="651"/>
<end position="697"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory linker">
<location>
<begin position="693"/>
<end position="754"/>
</location>
</feature>
<feature type="region of interest" description="6 X 2 AA tandem repeats of K-G">
<location>
<begin position="1109"/>
<end position="1120"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the PRC2/EED-EZH2 complex" evidence="18">
<location>
<begin position="1121"/>
<end position="1616"/>
</location>
</feature>
<feature type="region of interest" description="Catalytic">
<location>
<begin position="1139"/>
<end position="1616"/>
</location>
</feature>
<feature type="region of interest" description="S-adenosyl-L-methionine binding" evidence="19">
<location>
<begin position="1150"/>
<end position="1151"/>
</location>
</feature>
<feature type="region of interest" description="S-adenosyl-L-methionine binding" evidence="2 38">
<location>
<begin position="1168"/>
<end position="1169"/>
</location>
</feature>
<feature type="region of interest" description="S-adenosyl-L-methionine binding" evidence="19">
<location>
<begin position="1190"/>
<end position="1191"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="20">
<location>
<begin position="177"/>
<end position="205"/>
</location>
</feature>
<feature type="active site">
<location>
<position position="1226"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="353"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="356"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="414"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="418"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine; via carbonyl oxygen" evidence="19">
<location>
<position position="1146"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine" evidence="2 38">
<location>
<position position="1191"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine; via carbonyl oxygen" evidence="2 38">
<location>
<position position="1578"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine; via amide nitrogen" evidence="19">
<location>
<position position="1580"/>
</location>
</feature>
<feature type="site" description="Important for activity" evidence="18">
<location>
<position position="509"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="33">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 10 12 14 15">
<location>
<position position="127"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="133"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="137"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; by SETD7" evidence="37">
<location>
<position position="142"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1" evidence="10 15 37">
<location>
<position position="143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 15 40">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="160"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="173"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="188"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="42">
<location>
<position position="259"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13 15">
<location>
<position position="394"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="509"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="549"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 13 14 15">
<location>
<position position="714"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="732"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="749"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="878"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="891"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="957"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="961"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="975"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="1054"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11 42">
<location>
<position position="1111"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11 42">
<location>
<position position="1113"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11 42">
<location>
<position position="1115"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EHMT2" evidence="42">
<location>
<position position="1117"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="1119"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="1121"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="1349"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="42">
<location>
<position position="1415"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="17">
<location>
<position position="259"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17">
<location>
<position position="1609"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_005617" evidence="47">
<location>
<begin position="1"/>
<end position="336"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005618" evidence="46">
<original>P</original>
<variation>RSRDPPASASQVTGIRA</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16999593." id="VAR_024605">
<original>H</original>
<variation>R</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2228612." id="VAR_051960">
<original>I</original>
<variation>V</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In HSN1E; unstable protein with decreased enzymatic activity and impaired heterochromatin binding ability after the S phase; dbSNP:rs199473691." id="VAR_065965">
<original>DP</original>
<variation>EY</variation>
<location>
<begin position="490"/>
<end position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In HSN1E; unstable protein with decreased enzymatic activity and impaired heterochromatin binding ability after the S phase; dbSNP:rs199473690." id="VAR_065966" evidence="39">
<original>Y</original>
<variation>C</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence variant" description="In ADCADN; dbSNP:rs397509392." id="VAR_070055" evidence="43">
<original>A</original>
<variation>V</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="sequence variant" description="In ADCADN; dbSNP:rs397509393." id="VAR_070056" evidence="43">
<original>G</original>
<variation>A</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In ADCADN; dbSNP:rs397509391." id="VAR_070057" evidence="43">
<original>V</original>
<variation>F</variation>
<location>
<position position="590"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="45">
<original>R</original>
<variation>A</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="45">
<original>Q</original>
<variation>A</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="45">
<original>T</original>
<variation>A</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="45">
<original>I</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of interaction with PCNA." evidence="45">
<original>S</original>
<variation>A</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="45">
<original>H</original>
<variation>V</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="45">
<original>F</original>
<variation>V</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of interaction with PCNA." evidence="45">
<original>A</original>
<variation>S</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of interaction with PCNA." evidence="45">
<original>K</original>
<variation>A</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity about 10-fold; when associated with G-656; G-659; G-664; G-667 and G-670." evidence="34">
<original>C</original>
<variation>G</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity about 10-fold; when associated with G-653; G-659; G-664; G-667 and G-670." evidence="34">
<original>C</original>
<variation>G</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity about 10-fold; when associated with G-653; G-656; G-664; G-667 and G-670." evidence="34">
<original>C</original>
<variation>G</variation>
<location>
<position position="659"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity about 10-fold; when associated with G-653; G-656; G-659; G-667 and G-670." evidence="34">
<original>C</original>
<variation>F</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity about 10-fold; when associated with G-653; G-656; G-659; G-664 and G-670." evidence="34">
<original>C</original>
<variation>G</variation>
<location>
<position position="667"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity about 10-fold; when associated with G-653; G-656; G-659; G-664 and G-667." evidence="34">
<original>C</original>
<variation>G</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="36">
<original>C</original>
<variation>A</variation>
<location>
<position position="1226"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="359"/>
<end position="361"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="377"/>
<end position="381"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="404"/>
<end position="414"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="422"/>
<end position="425"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="426"/>
<end position="430"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="433"/>
<end position="440"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="453"/>
<end position="458"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="463"/>
<end position="467"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="470"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="476"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="485"/>
<end position="488"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="493"/>
<end position="495"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="496"/>
<end position="518"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="524"/>
<end position="533"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="538"/>
<end position="540"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="547"/>
<end position="551"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="554"/>
<end position="566"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="575"/>
<end position="578"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="579"/>
<end position="588"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="592"/>
<end position="597"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="622"/>
<end position="629"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="657"/>
<end position="659"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="670"/>
<end position="672"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="674"/>
<end position="677"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="687"/>
<end position="689"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="692"/>
<end position="703"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="731"/>
<end position="735"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="738"/>
<end position="740"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="744"/>
<end position="746"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="748"/>
<end position="752"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="755"/>
<end position="758"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="762"/>
<end position="765"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="767"/>
<end position="769"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="775"/>
<end position="785"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="786"/>
<end position="788"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="789"/>
<end position="799"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="800"/>
<end position="802"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="803"/>
<end position="805"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="806"/>
<end position="808"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="813"/>
<end position="824"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="825"/>
<end position="827"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="828"/>
<end position="832"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="834"/>
<end position="836"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="843"/>
<end position="845"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="851"/>
<end position="853"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="856"/>
<end position="860"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="862"/>
<end position="870"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="871"/>
<end position="874"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="875"/>
<end position="877"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="886"/>
<end position="888"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="889"/>
<end position="891"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="894"/>
<end position="905"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="912"/>
<end position="916"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="921"/>
<end position="928"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="931"/>
<end position="934"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="938"/>
<end position="941"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="966"/>
<end position="968"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="973"/>
<end position="975"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="976"/>
<end position="980"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="992"/>
<end position="1001"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1005"/>
<end position="1008"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1015"/>
<end position="1020"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1024"/>
<end position="1026"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1031"/>
<end position="1034"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1035"/>
<end position="1037"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1041"/>
<end position="1044"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1048"/>
<end position="1052"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1053"/>
<end position="1055"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1058"/>
<end position="1064"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1065"/>
<end position="1067"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1072"/>
<end position="1077"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1079"/>
<end position="1090"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1091"/>
<end position="1094"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1095"/>
<end position="1097"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1101"/>
<end position="1103"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1139"/>
<end position="1145"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1150"/>
<end position="1158"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1160"/>
<end position="1167"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1171"/>
<end position="1180"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1184"/>
<end position="1187"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1191"/>
<end position="1200"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1214"/>
<end position="1216"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1218"/>
<end position="1222"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1231"/>
<end position="1233"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1237"/>
<end position="1243"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1247"/>
<end position="1258"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1261"/>
<end position="1268"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1269"/>
<end position="1272"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1275"/>
<end position="1277"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1278"/>
<end position="1289"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1293"/>
<end position="1300"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1301"/>
<end position="1304"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1311"/>
<end position="1318"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1336"/>
<end position="1338"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1343"/>
<end position="1345"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1348"/>
<end position="1350"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1367"/>
<end position="1371"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1384"/>
<end position="1386"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1395"/>
<end position="1401"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1419"/>
<end position="1426"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1436"/>
<end position="1438"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1451"/>
<end position="1453"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1462"/>
<end position="1464"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1474"/>
<end position="1476"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1477"/>
<end position="1479"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1480"/>
<end position="1482"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1487"/>
<end position="1489"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1493"/>
<end position="1496"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1499"/>
<end position="1503"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1504"/>
<end position="1506"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1508"/>
<end position="1510"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1511"/>
<end position="1514"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1523"/>
<end position="1525"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1534"/>
<end position="1536"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1542"/>
<end position="1547"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1550"/>
<end position="1556"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1569"/>
<end position="1578"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1582"/>
<end position="1598"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EPZ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PTA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SWR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WXX"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YOC"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WVO"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5YDR"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250"/>
<evidence key="19" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P13864"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255"/>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00370"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00509"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01016"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01260"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10018"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10325416"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10888872"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10888886"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10947852"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12145218"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16357870"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18413740"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18438403"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18754681"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19173286"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19450230"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21151116"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21163962"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21532572"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21565170"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21745816"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21947282"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22328086"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24623306"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9302295"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="48" type="ECO:0000305"/>
<sequence length="1616" mass="183165" checksum="1E833192D22AFA5B" modified="2001-01-11" version="2">MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLHEFLQTEIKNQLCDLETKLRKEELSEEGYLAKVKSLLNKDLSLENGAHAYNREVNGRLENGNQARSEARRVGMADANSPPKPLSKPRTPRRSKSDGEAKPEPSPSPRITRKSTRQTTITSHFAKGPAKRKPQEESERAKSDESIKEEDKDQDEKRRRVTSRERVARPLPAEEPERAKSGTRTEKEEERDEKEEKRLRSQTKEPTPKQKLKEEPDREARAGVQADEDEDGDEKDEKKHRSQPKDLAAKRRPEEKEPEKVNPQISDEKDEDEKEEKRRKTTPKEPTEKKMARAKTVMNSKTHPPKCIQCGQYLDDPDLKYGQHPPDAVDEPQMLTNEKLSIFDANESGFESYEALPQHKLTCFSVYCKHGHLCPIDTGLIEKNIELFFSGSAKPIYDDDPSLEGGVNGKNLGPINEWWITGFDGGEKALIGFSTSFAEYILMDPSPEYAPIFGLMQEKIYISKIVVEFLQSNSDSTYEDLINKIETTVPPSGLNLNRFTEDSLLRHAQFVVEQVESYDEAGDSDEQPIFLTPCMRDLIKLAGVTLGQRRAQARRQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKRRRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEADDDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKVCIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMDPESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLAEMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTFNIKLSSPVKRPRKEPVDEDLYPEHYRKYSDYIKGSNLDAPEPYRIGRIKEIFCPKKSNGRPNETDIKIRVNKFYRPENTHKSTPASYHADINLLYWSDEEAVVDFKAVQGRCTVEYGEDLPECVQVYSMGGPNRFYFLEAYNAKSKSFEDPPNHARSPGNKGKGKGKGKGKPKSQACEPSEPEIEIKLPKLRTLDVFSGCGGLSEGFHQAGISDTLWAIEMWDPAAQAFRLNNPGSTVFTEDCNILLKLVMAGETTNSRGQRLPQKGDVEMLCGGPPCQGFSGMNRFNSRTYSKFKNSLVVSFLSYCDYYRPRFFLLENVRNFVSFKRSMVLKLTLRCLVRMGYQCTFGVLQAGQYGVAQTRRRAIILAAAPGEKLPLFPEPLHVFAPRACQLSVVVDDKKFVSNITRLSSGPFRTITVRDTMSDLPEVRNGASALEISYNGEPQSWFQRQLRGAQYQPILRDHICKDMSALVAARMRHIPLAPGSDWRDLPNIEVRLSDGTMARKLRYTHHDRKNGRSSSGALRGVCSCVEAGKACDPAARQFNTLIPWCLPHTGNRHNHWAGLYGRLEWDGFFSTTVTNPEPMGKQGRVLHPEQHRVVSVRECARSQGFPDTYRLFGNILDKHRQVGNAVPPPLAKAIGLEIKLCMLAKARESASAKIKEEEAAKD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>